These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16027518)

  • 1. Novel treatment strategies in clear-cell metastatic renal cell carcinoma.
    van Spronsen DJ; de Weijer KJ; Mulders PF; De Mulder PH
    Anticancer Drugs; 2005 Aug; 16(7):709-17. PubMed ID: 16027518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel treatments for metastatic renal cell carcinoma.
    van Spronsen DJ; Mulders PF; De Mulder PH
    Crit Rev Oncol Hematol; 2005 Sep; 55(3):177-91. PubMed ID: 15979888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling inhibitors in metastatic renal cell carcinoma.
    Escudier B
    Cancer J; 2008; 14(5):325-9. PubMed ID: 18836338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted treatment for metastatic renal cell carcinoma and immune regulation.
    Laschos KA; Papazisis KT; Kontovinis LF; Kalaitzis C; Gianakopoulos S; Kortsaris AH; Touloupidis S
    J BUON; 2010; 15(2):235-40. PubMed ID: 20658715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current immunotherapeutic strategies in renal cell carcinoma.
    Amato RJ
    Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced renal cell carcinoma: current and emerging management strategies.
    Escudier B
    Drugs; 2007; 67(9):1257-64. PubMed ID: 17547470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review.
    Raman R; Vaena D
    Biomed Res Int; 2015; 2015():367354. PubMed ID: 26161397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapies for kidney cancer in urologic practice.
    Haas NB; Uzzo RG
    Urol Oncol; 2007; 25(5):420-32. PubMed ID: 17826664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted agents for the treatment of advanced renal cell carcinoma.
    Staehler M; Rohrmann K; Haseke N; Stief CG; Siebels M
    Curr Drug Targets; 2005 Nov; 6(7):835-46. PubMed ID: 16305462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies.
    Golshayan AR; Brick AJ; Choueiri TK
    Future Oncol; 2008 Feb; 4(1):85-92. PubMed ID: 18241003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conclusion and future directions.
    Samlowski WE; Vogelzang NJ
    Cancer J; 2008; 14(5):330-2. PubMed ID: 18836339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to overcome therapeutic resistance in renal cell carcinoma.
    Siska PJ; Beckermann KE; Rathmell WK; Haake SM
    Urol Oncol; 2017 Mar; 35(3):102-110. PubMed ID: 28089416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted approaches for treating advanced clear cell renal carcinoma.
    van Spronsen DJ; De Mulder PH
    Onkologie; 2006 Sep; 29(8-9):394-402. PubMed ID: 16974118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
    Choueiri TK; Vaziri SA; Jaeger E; Elson P; Wood L; Bhalla IP; Small EJ; Weinberg V; Sein N; Simko J; Golshayan AR; Sercia L; Zhou M; Waldman FM; Rini BI; Bukowski RM; Ganapathi R
    J Urol; 2008 Sep; 180(3):860-5; discussion 865-6. PubMed ID: 18635227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging immunotherapies for renal cell carcinoma.
    Escudier B
    Ann Oncol; 2012 Sep; 23 Suppl 8():viii35-40. PubMed ID: 22918926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.
    Kirner A; Mayer-Mokler A; Reinhardt C
    Hum Vaccin Immunother; 2014; 10(11):3179-89. PubMed ID: 25625928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in renal cell carcinoma.
    Heine A; Holderried TA; Brossart P
    Immunotherapy; 2009 Jan; 1(1):97-107. PubMed ID: 20635977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab as a treatment option in advanced renal cell carcinoma: an analysis and interpretation of clinical trial data.
    McDermott DF; George DJ
    Cancer Treat Rev; 2010 May; 36(3):216-23. PubMed ID: 20116176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in the management of advanced renal cell carcinoma.
    Garcia JA; Rini BI
    CA Cancer J Clin; 2007; 57(2):112-25. PubMed ID: 17392388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunotherapeutic strategies in development for renal cell carcinoma.
    Inman BA; Harrison MR; George DJ
    Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.